Contact
Please use this form to send email to PR contact of this press release:
Altimmune Announces $14.7 Million Series B Preferred Stock Offering
TO:
Please use this form to send email to PR contact of this press release:
Altimmune Announces $14.7 Million Series B Preferred Stock Offering
TO: